ENOV Enovis Corporation
USHealthcareAs of 2026-07-10 16:00
Why ENOV matters now
Enovis Corporation (ENOV) is a US stock in Healthcare. The latest InvestLog snapshot shows $25.75 with +2.10% on the session and $1.48B in market capitalization; recent performance reads 1-month -14.71% and YTD -17.53%.
The latest financial table shown here is Q1 2026, with revenue of $589.2M, net income of $-8.8M, and EPS of $-0.15. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 2.8%.
The latest indexable market news headline is "4 Top Growth Stocks Worth Buying Under $100 Today" from Fool - Investing News.
Additional event context on this page matters because analyst consensus is Buy with a median target of $45.50; recent insider activity includes Engert Oliver filing P-Purchase. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.84
P/S
0.56
EV/EBITDA
-3.53
DCF Value
$-117.46
FCF Yield
2.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
56.8%
Operating Margin
2.7%
Net Margin
-49.9%
ROE
-60.1%
ROA
-29.7%
ROIC
1.9%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $589.2M | $-8.8M | $-0.15 |
| Q4 2025 | $575.8M | $-520.6M | $-9.17 |
| FY 2025 | $2.25B | $-1.18B | $-20.86 |
| Q3 2025 | $548.9M | $-571.1M | $-10.06 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$44.75
Target (Median)
$45.50
Target Range
$36.00 - $52.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
1.49
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.